Product Information
AMETHYST 90-20 MCG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.1928 per EA under NDC 00480347224. Its NADAC has been published 166 times since Apr 26, 2023.
Strength
20; 90 ug/1; ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480347224
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA079218On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for AMETHYST 90-20 MCG TABLET has been published 166 times since Apr 26, 2023, and over the history we have for it it has risen 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1928 per EA |
|---|---|
| All-time high | $1.3471 (Jul 12, 2023) |
| All-time low | $0.7929 (Nov 20, 2024) |
| 52-week high | $1.2766 |
| 52-week low | $1.1928 |
| Median price | $1.2001 |
| Average price | $1.1365 |
| Largest weekly change | -28.9% (Nov 20, 2024) |
| Weeks tracked | 166 |
| Tracking since | Apr 26, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMETHYST 90-20 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMETHYST 90-20 MCG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.1928 per EA (NDC 00480347224), effective Jun 24, 2026.
How has the price of AMETHYST 90-20 MCG TABLET changed over time?
Over the history we have for it, the NADAC for AMETHYST 90-20 MCG TABLET has risen 8.3%. It has been tracked across 166 weekly CMS publications since Apr 26, 2023.
What are the highest and lowest recorded NADAC prices for AMETHYST 90-20 MCG TABLET?
Since Apr 26, 2023, the NADAC for AMETHYST 90-20 MCG TABLET has ranged from a low of $0.7929 (Nov 20, 2024) to a high of $1.3471 (Jul 12, 2023), with a median of $1.2001 per EA.
Are there cheaper alternatives to AMETHYST 90-20 MCG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as AMETHYST 90-20 MCG TABLET, but none are currently priced below it.
Who manufactures AMETHYST 90-20 MCG TABLET?
AMETHYST 90-20 MCG TABLET (NDC 00480347224) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification